Aimovig - Contact form - HCP

Speak to a Novartis representative

This page/content is for Great Britain healthcare professionals only. If you require information for Northern Ireland please refer to the Northern Ireland electronic medicines compendium (emc).


Please complete this form to be contacted by a Novartis promotional representative in your area. Fields marked * below are mandatory.

Your information will be used to put you in contact with a Novartis representative and handled in accordance with our Privacy Notice.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

UK | October 2024 |  FA-11214838

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.

Source URL: https://www.pro.novartis.com/uk-en/medicines/neuroscience/aimovig/contact